Key calculated variables in the AVF P2 in systole (upper row) and diastole (lower row). by Tatiana Yu Salikhova (13899409)

Key calculated variables in the AVF P1 in systole (upper row) and diastole (lower row). by Tatiana Yu Salikhova (13899409)

DataSheet_1_Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.docx by Eva Schrezenmeier (6261917)

“…In a longitudinal follow-up at ~10 weeks after the second dose, the proportion of dialysis patients reactive for anti-SARS-CoV-2-IgG decreased to 27/32 (84.37%, 95%CI: 66.46–94.10) The proportion of anti-SARS-CoV-2 S1 IgA decreased from 33/36 (91.67%; 95%CI: 76.41–97.82) at weeks 3–4 down to 19/32 (59.38; 95%CI: 40.79–75.78). …”

DataSheet_1_Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.docx by Eva Schrezenmeier (6261917)

“…In a longitudinal follow-up at ~10 weeks after the second dose, the proportion of dialysis patients reactive for anti-SARS-CoV-2-IgG decreased to 27/32 (84.37%, 95%CI: 66.46–94.10) The proportion of anti-SARS-CoV-2 S1 IgA decreased from 33/36 (91.67%; 95%CI: 76.41–97.82) at weeks 3–4 down to 19/32 (59.38; 95%CI: 40.79–75.78). …”

Metabolic activity and AST levels of human hepatocytes after treatment with levosimendan. by Stefanie N. Brunner (4598818)

Fig 4 - by Bilal Ahmad (773365)

Evaluation of the impact of dental prophylaxis on the oral microbiota of dogs by Rebecca Flancman (5447552)

“…A subsample of 10 dogs was followed, and additional samples were collected two and five weeks post-prophylaxis. …”

Mathematical model diagram. by Kanyarat Jitmana (18693060)

Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation by Jelmer J. Dijkstra (14198102)

Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation by Jelmer J. Dijkstra (14198102)

Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation by Jelmer J. Dijkstra (14198102)

Histopathology of the spleen tissues. by Landa Zeenelabdin Ali Salim (677988)

Relative amount of Bcl-2 and BAX after treatment with levosimendan. by Stefanie N. Brunner (4598818)

Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media by Tasnee Chonmaitree (549394)

“…While <i>Sphingobium</i> may play a role in preventing AOM complicating URI, the commonly used probiotic <i>Bifidobacterium</i> did not play a significant role during URI or AOM. …”

<em>Nicotiana benthamiana</em> as a Production Platform for Artemisinin Precursors by Teun W. J. M. van Herpen (235906)

“…However, analysis of leaf extracts with a non-targeted metabolomics approach, using LC-QTOF-MS, revealed the presence of another compound, which was identified as artemisinic acid-12-β-diglucoside. …”

Total number of apoptotic hepatocytes after treatment with levosimendan. by Stefanie N. Brunner (4598818)

Schematic of the basic single-step cell state model. by Anshul Saini (11320669)

Fig 6 - by Tatiana Yu Salikhova (13899409)

Architecture of SDVGG16. by Wanchalerm Pora (8360934)

<i>C</i>_S‑Symmetric Pyridine(diimine) Iron Methyl Complexes for Catalytic [2+2] Cycloaddition and Hydrovinylation: Metallacycle Geometry Determines Selectivity by Coralie Duchemin (6974873)

“…A series of <i>C</i>_S-symmetric (aryl,alkyl)-substituted pyridine(dimine) iron methyl (^CyA^RPDI)FeCH₃ complexes have been prepared, characterized, and evaluated as precatalysts for the [2+2]-cycloaddition of butadiene and ethylene. …”